A brief GP intervention for weight loss: The BWeL-B feasibility trial
- Conditions
- ObesityNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN72298614
- Lead Sponsor
- niversity of Oxford
- Brief Summary
2020 results in https://pubmed.ncbi.nlm.nih.gov/32094219/ (added 15/01/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 93
1. Body mass index (BMI) >30 kg/m2 (or >25 kg/m2 for South Asian population groups) and excess body fat
2. Aged 18 years or over
3. Participant is willing and able to give informed consent for participation in the study and comply with study procedures.
1. Pregnant or imminently intending to become pregnant
2. Persons with pacemakers or other electronic medical implants
3. Currently or within the past three months participated in a weight management programme (including pharmacotherapy or bariatric surgery)
4. Visiting the GP for weight management
5. GP deems it inappropriate to make an opportunistic intervention on weight management. This includes personal medical reasons known to the GP, such as an eating disorder, or reasons related to the consultation e.g. the patient has become distressed and it would seem insensitive to make such an intervention at this time. If the GP does not consider it appropriate, then the patient will not be enrolled and randomised into the trial (see section 7.5 Randomisation, blinding, and code breaking).
6. Unable to understand and speak English sufficiently to give informed consent and complete the research assessments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attendance at weight management programme assessed using participant report via telephone at 3 weeks after the consultation.
- Secondary Outcome Measures
Name Time Method